苏利股份(603585) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥457,010,929.39, a decrease of 42.25% compared to the same period last year[6]. - The net profit attributable to shareholders was -¥3,957,085.78, reflecting a decline of 106.00% year-on-year[6]. - The basic earnings per share for the quarter was -¥0.02, down 105.41% from the previous year[6]. - Total operating revenue for the first three quarters of 2023 was ¥1,482,057,994.45, a decrease of 39.0% compared to ¥2,434,674,002.42 in the same period of 2022[21]. - Net profit for the first three quarters of 2023 was ¥34,804,675.84, a significant decline of 89.5% compared to ¥332,925,239.41 in the same period of 2022[23]. - Earnings per share for the first three quarters of 2023 were ¥0.20, down from ¥1.47 in the same period of 2022[24]. - The total comprehensive income for the first three quarters of 2023 was ¥34,861,321.98, a decrease of 89.5% from ¥332,895,780.82 in the same period of 2022[24]. Assets and Liabilities - The total assets at the end of the reporting period were ¥5,464,580,761.90, representing a 2.77% increase from the end of the previous year[6]. - The total equity attributable to shareholders was ¥2,545,988,617.02, a decrease of 2.70% from the previous year-end[6]. - Total liabilities increased to ¥2,342,664,506.83 in 2023 from ¥1,974,979,617.75 in 2022, representing a growth of 18.6%[19]. - The company's current assets decreased to CNY 2,611,563,150.36 from CNY 3,181,404,276.54 year-over-year, reflecting a decline of approximately 17.9%[16]. - Accounts receivable decreased to CNY 271,699,839.95 from CNY 350,461,210.94, representing a decline of approximately 22.5%[16]. - Inventory levels also fell to CNY 287,008,958.74 from CNY 351,917,979.87, a decrease of around 18.4%[16]. - Total equity attributable to shareholders decreased to ¥2,545,988,617.02 in 2023 from ¥2,616,563,559.03 in 2022, a decline of 2.7%[19]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥244,932,607.80, a decrease of 40.92% compared to the same period last year[6]. - In the first three quarters of 2023, the cash inflow from operating activities was CNY 1,613,385,877.41, a decrease of 34.3% compared to CNY 2,456,121,192.22 in the same period of 2022[26]. - The cash outflow from investment activities totaled CNY 518,011,833.66, significantly lower than CNY 1,437,985,817.49 in the same period last year, indicating a reduction of 63.9%[29]. - The net cash flow from financing activities was negative at CNY -209,442,746.28, contrasting sharply with a positive CNY 886,896,239.03 in the previous year[29]. - The total cash and cash equivalents at the end of the third quarter of 2023 stood at CNY 1,278,017,206.04, down from CNY 1,634,632,349.82 at the end of the same period in 2022[30]. - The cash inflow from financing activities was CNY 56,332,806.87, a decrease of 95.1% from CNY 1,141,412,160.53 in the previous year[29]. Operational Challenges - The decline in revenue and profit was primarily due to cyclical fluctuations in the pesticide industry and slow recovery in global supply chains, leading to decreased demand[10]. - The company reported a decrease in sales prices and quantities for its main products, impacting overall profitability despite some stabilization in demand for certain products[10]. - Research and development expenses for the first three quarters of 2023 were ¥83,330,428.00, down 16.3% from ¥99,519,020.80 in the same period of 2022[21]. - The company experienced a significant drop in both diluted and basic earnings per share, with diluted earnings per share at ¥0.00, down 100.00% year-on-year[6]. - Non-recurring gains and losses for the quarter included a loss from the disposal of non-current assets amounting to -¥66,853.73[8].